The study, which is peer-reviewed and published in Science introduces a “living, cell-based implant” that works as a pancreas ...

A pioneering study marks a major step toward eliminating the need for daily insulin injections for people with diabetes. The ...

SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing a fully human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other autoimmune ...

Global Mice Model Market OverviewThe global mice model market is projected to grow at an approximate rate of 9% over the next five years, supported by increasing demand for personalized medicine, ...

Professor Lisa Volpatti developed a targeted approach that directs anti-inflammatory proteins to diseased arteries, reducing ...

JERUSALEM, Feb. 2 (Xinhua) -- Researchers in Israel and the United States have developed a living implant that acts as an artificial pancreas, a breakthrough that could one day eliminate the need for ...

The National Academy of Sciences is presenting its 2026 Public Welfare Medal to Staunton native Francis S. Collins, a former ...

The conferees include aerospace engineer Chandramouli Gaddamanugu, who directed the Akash missile system from the development ...

The National Academy of Sciences is presenting its 2026 Public Welfare Medal to Francis S. Collins, former director, National Institutes of Health (NIH), for his pioneering research in human genetics ...

Yee is joined by two other bullish analysts who are even more optimistic on the stock, earning it a Strong Buy consensus ...

Leon Wang's grandfather died due to the effects of Alzheimer's, so the King School senior set about finding a way to slow the progress of the disease for his winning project.

MIAMI, Jan. 06, 2026 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes ...